Update on the European Vasculitis Study Group trials
Author:
- 1 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 13 (1) , 48-55
Abstract
Over the last fifteen years, collaborative vasculitis studies in Europe have established the association of antineutrophil cytoplasmic antibodies (ANCA) with vasculitis and defined its clinical role as a diagnostic tool. More recently, the European Vasculitis Study Group has developed a consensus approach to the treatment of vasculitis and has aimed to harmonize and optimize current therapy by a series of multicenter randomized controlled trials. The first trial to report, CYClophosphamide or AZathioprine As a REMission therapy for vasculitis (CYCAZAREM), demonstrated that, for generalized vasculitis, azathioprine is as effective as continued cyclophosphamide for the maintenance of remission. Other trials are investigating the roles of methotrexate, plasma exchange, and pulse cyclophosphamide in acute disease, and strategies to prevent relapse over the longer term. Parallel studies are determining prognostic markers, evaluating tools for monitoring disease, and examining the association of ANCA and infection with relapse. The established infrastructure and accumulated database are well placed to facilitate testing of newer therapeutic strategies in the future.Keywords
This publication has 51 references indexed in Scilit:
- Pathogenesis of ANCA-associated systemic vasculitisThe Journal of Pathology, 2000
- International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)American Journal of Clinical Pathology, 1999
- Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitisKidney International, 1998
- 10 Disease assessment and management of the vasculitidesBailliere's Clinical Rheumatology, 1997
- The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreementNephrology Dialysis Transplantation, 1996
- Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) A report on the second phase of an international cooperative study on the standardization of ANCA assaysJournal of Immunological Methods, 1996
- European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078)Clinical and Experimental Immunology, 1995
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- ANTI-NEUTROPHIL CYTOPLASM ANTIBODIES 1988The Lancet, 1988
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985